Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Eli Lilly and Company
Eli Lilly and Company
Tempus AI
AO GENERIUM
Klus Pharma Inc.
Quadriga Biosciences, Inc.
Celldex Therapeutics
Merck Sharp & Dohme LLC